Indirubin Treatment of Lipopolysaccharide-Induced Mastitis in a Mouse Model and Activity in Mouse Mammary Epithelial Cells

Variant innate immune responses of mammary epithelial cells to challenge by Staphylococcus aureus, Escherichia coli and the regulating effect of taurine on these bioprocesses

(2016) Liuhai Zheng et al.   FREE RADICAL BIOLOGY AND MEDICINE

Indirubin and Indirubin Derivatives for Counteracting Proliferative Diseases

(2015) Tina Blažević et al.   Evidence-based Complementary and Alternative Medicine

Liposomes and MTT cell viability assay: An incompatible affair

(2015) Fabrizio Angius et al.   TOXICOLOGY IN VITRO

A novel pro-inflammatory protein of Streptococcus suis 2 induces the Toll-like receptor 2-dependent expression of pro-inflammatory cytokines in RAW 264.7 macrophages via activation of ERK1/2 pathway

(2015) Qiang Zhang et al.   Frontiers in Microbiology

Magnolol Inhibits the Inflammatory Response in Mouse Mammary Epithelial Cells and a Mouse Mastitis Model

(2014) Wang Wei et al.   INFLAMMATION

Oxymatrine Lightened the Inflammatory Response of LPS-Induced Mastitis in Mice Through Affecting NF-κB and MAPKs Signaling Pathways

(2014) Zhengtao Yang et al.   INFLAMMATION

Stevioside Plays an Anti-inflammatory Role by Regulating the NF-κB and MAPK Pathways in S. aureus-infected Mouse Mammary Glands

(2014) Tiancheng Wang et al.   INFLAMMATION

Emodin ameliorates lipopolysaccharide-induced mastitis in mice by inhibiting activation of NF-κB and MAPKs signal pathways

(2013) Depeng Li et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Astragalin suppresses inflammatory responses via down-regulation of NF-κB signaling pathway in lipopolysaccharide-induced mastitis in a murine model

(2013) Fengyang Li et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

A Novel Herbal Medicine KIOM-MA Exerts an Anti-Inflammatory Effect in LPS-Stimulated RAW 264.7 Macrophage Cells

(2012) You-Chang Oh et al.   Evidence-based Complementary and Alternative Medicine

NF- B, the first quarter-century: remarkable progress and outstanding questions

(2012) M. S. Hayden et al.   GENES & DEVELOPMENT

Invited review: Mastitis in dairy heifers: Nature of the disease, potential impact, prevention, and control

(2012) S. De Vliegher et al.   JOURNAL OF DAIRY SCIENCE

5′-Nitro-indirubinoxime, an indirubin derivative, suppresses metastatic ability of human head and neck cancer cells through the inhibition of Integrin β1/FAK/Akt signaling

(2011) Soo-A Kim et al.   CANCER LETTERS

Indirubin-3-monoxime exhibits anti-inflammatory properties by down-regulating NF-κB and JNK signaling pathways in lipopolysaccharide-treated RAW264.7 cells

(2011) Jin-Kyung Kim et al.   INFLAMMATION RESEARCH

Indirubin-3'-monoxime, a derivative of a chinese antileukemia medicine, inhibits angiogenesis

(2011) Jin-Kyung Kim et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Recombinant MPT83 Derived from Mycobacterium tuberculosis Induces Cytokine Production and Upregulates the Function of Mouse Macrophages through TLR2

(2011) S.-T. Chen et al.   JOURNAL OF IMMUNOLOGY

Effect of indirubin-3-monoxime against lung cancer as evaluated by histological and transmission electron microscopic studies

(2010) Kameswaran Ravichandran et al.   MICROSCOPY RESEARCH AND TECHNIQUE

Indirubin-3′-oxime prevents hepatic I/R damage by inhibiting GSK-3β and mitochondrial permeability transition

(2010) Ana T. Varela et al.   MITOCHONDRION

Regulation and Function of NF-κB Transcription Factors in the Immune System

(2009) Sivakumar Vallabhapurapu et al.   Annual Review of Immunology

Expression profile of genes associated with mastitis in dairy cattle

(2009) Isabela Fonseca et al.   GENETICS AND MOLECULAR BIOLOGY

In liver fibrosis, dendritic cells govern hepatic inflammation in mice via TNF-α

(2009) Michael K. Connolly et al.   JOURNAL OF CLINICAL INVESTIGATION

Antiproliferative and apoptosis inducing effects of indirubin-3′-monoxime in renal cell cancer cells

(2009) Frank G.E. Perabo et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Indirubin-3′-monoxime, a derivative of a Chinese anti-leukemia medicine, inhibits Notch1 signaling

(2008) Mi-Jee Lee et al.   CANCER LETTERS